Synteract focusing on specific therapeutic areas as it eyes market growth

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/showcake)
(Image: iStock/showcake)
The contract research organization (CRO) Synteract today announced the creation of “therapeutic centers of development” as it looks to deepen its footprint in the mid-size CRO market space.

According to the company, the centers of development will include oncology – especially immunotherapy studies – pediatrics, neuro-degenerative disorders, as well as rare and orphan diseases.

"Our centers of therapeutic development are areas of specific focus where we have a lot of experience,"​ Synteract CEO Steve Powell told us. 

The CRO will continue to support other therapeutic areas where clients have needs, he explained; "However, by more clearly defining our areas of ​specialization we have an opportunity to make it easier to answer 'Why Synteract?'"

Echoing this sentiment in the press release, chief commercial officer Jack Shannon said that by “more clearly delineating”​ the company’s attention on “these growing development areas”​ it will have “a real opportunity”​ to expand its presence in the mid-market space​.

The new position was created in collaboration with its customers and internal teams, according to the company. 

Related news

Show more

Related products

show more

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Covance Touchless Drug and Device Vigilance Vision

Covance Touchless Drug and Device Vigilance Vision

Covance Patient Safety | 01-Sep-2020 | Data Sheet

Automation tools enable organizations to identify patterns in structured and unstructured data and facilitate automation of the entire product vigilance...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Related suppliers

Follow us

Products

View more

Webinars